BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24225128)

  • 1. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
    Shen L; Peng H; Zhao S; Xu D
    Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
    Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of soluble epoxide hydrolase inhibitors on cholesterol efflux in adipocytes].
    Jiang Y; Xu DY; Zhao SP; Liu YW; Zhao TT; DU JQ
    Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):235-9. PubMed ID: 21600089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of soluble epoxide hydrolase inhibitors on lipid metabolism and secretive functions of adipocytes].
    Jiang Y; Xu DY; Zhao TT; DU JQ; Peng DQ; Zhao SP
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):111-6. PubMed ID: 21418994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble epoxide hydrolase inhibitor t-AUCB ameliorates ox-LDL induced conversion of macrophages into foam cells through activating the PPARγ-ABCA1 pathway].
    Zhao TT; Peng R; Shen L; Zhao X; Xu DY; Zhao SP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):248-52. PubMed ID: 22801272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
    Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
    Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of oxidized low-density lipoprotein on LXR-ABCA1-apoA-I pathway in 3T3-L1 cells.
    Zhao SP; Yu BL; Xie XZ; Dong SZ; Dong J
    Int J Cardiol; 2008 Aug; 128(1):42-7. PubMed ID: 17643522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphatase activity of soluble epoxide hydrolase regulates ATP-binding cassette transporter-A1-dependent cholesterol efflux.
    Lien CC; Chen CH; Lee YM; Guo BC; Cheng LC; Pan CC; Shyue SK; Lee TS
    J Cell Mol Med; 2019 Oct; 23(10):6611-6621. PubMed ID: 31436906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein increases the uptake of oxidized low density lipoprotein via PPARγ/CD36 pathway in inflammatory adipocytes.
    Zhong Q; Zhao S; Yu B; Wang X; Matyal R; Li Y; Jiang Z
    Int J Biol Sci; 2015; 11(3):256-65. PubMed ID: 25678844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.
    Roche C; Guerrot D; Harouki N; Duflot T; Besnier M; Rémy-Jouet I; Renet S; Dumesnil A; Lejeune A; Morisseau C; Richard V; Bellien J
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():148-54. PubMed ID: 26022136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Ledent C; Tilley SL; Nayeem MA
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():83-95. PubMed ID: 28890385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
    Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
    Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
    Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
    Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit.
    Zhao SP; Wu J; Zhang DQ; Ye HJ; Liu L; Li JQ
    Atherosclerosis; 2004 Dec; 177(2):255-62. PubMed ID: 15530897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of oxidized low-density lipoprotein on cholesterol efflux in 3T3-L1 cells].
    Yu BL; Zhao SP; Xie XZ; Dong SZ; Dong J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):631-6. PubMed ID: 17767055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
    Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
    Liu JY; Yang J; Inceoglu B; Qiu H; Ulu A; Hwang SH; Chiamvimonvat N; Hammock BD
    Biochem Pharmacol; 2010 Mar; 79(6):880-7. PubMed ID: 19896470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.